RecallHawk
Class II Recall

ProteusPLUS and ProteusONE- designed to produce and deliver a proton beam for the treatment of patients with localized t

Ion Beam Applications S.A.

Summary

The FDA issued a Class II for ProteusPLUS and ProteusONE- designed to produce and deliver a proton beam for th by Ion Beam Applications S.A.. Reason: When resuming from a beam pause, the Proton Therapy System does not verify whether the beam range has not been manually modified during the pause and .

Details

Source

Device Recall

External ID

Z-0747-2022

Action Date

2022-03-16

Status

Ongoing

Category

device

Product Description

ProteusPLUS and ProteusONE- designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation Proteus 235

Lot/Code Info: PAT.003 (KR), PAT.006 (US), PAT.107 (EU), PAT.108 (US), PAT109 (US), PAT.110 (US), PAT.111 (EU), PAT.112 (US), PAT.113 (US), PAT.114 (EU), PAT.115 (EU), SAT.116 (US), SAT.117 (EU), SAT.118 (RU), SAT.119 (US), SAT.120 (EU), SAT.122 (EU), SAT.123 (US), SAT.125 (IN), SAT.126 (US), SAT.127 (TW), SAT.132 (EU), SAT.133 (US), SAT.136 (IN), SAT.140 (US), SBF.101 (EU), SBF.103 (JP), SBF.104 (JP), SBF.105 (US), SBF.107 (FR), SBF.109 (UK), SBF.110 (UK), SBF.112 (EU), SBF.113 (US), SBF.115 (UK), SBF.117 (EU), SBF.128 (US). UDI: (01)05404013801138

Quantity Affected: 15 units US; 22 units OUS

Reason for Recall

When resuming from a beam pause, the Proton Therapy System does not verify whether the beam range has not been manually modified during the pause and is still the prescribed one. Therefore, if an operator manually modified the range during a pause, there is a risk that a portion of the treatment beam after the resume is delivered with an error in range

Distribution

IL, KS, LA, FL, MI, OK, PA, NJ, TN, TX, VA, WA Foreign: Belgium, England, Germany, France, Czech Republic, Italy, Poland, Russia, Spain, Sweden, South Korea, Taiwan, Netherlands,

Type: Voluntary: Firm initiated

Recall Initiated: 2022-02-15

Company

Ion Beam Applications S.A.

Louvain-la-neuve, N/A

Context & Analysis

This is a Class II recall. Class II recalls indicate that use of or exposure to the product may cause temporary or medically reversible health consequences, or that the probability of serious consequences is remote.

This was one of 143 device recalls issued in the same week, part of 403 device-related FDA actions this month.

Ion Beam Applications S.A. has 11 FDA actions in our database, including 11 recalls.

Frequently Asked Questions

What is a Class II recall?

A Class II recall means the product may cause temporary or medically reversible adverse health consequences, or the probability of serious adverse consequences is remote. Consumers should discontinue use.

What should I do if I have this product?

Stop using the product. Check the product against the specific lot numbers or identifiers listed in the recall. Contact the manufacturer (Ion Beam Applications S.A.) or your retailer for a refund or replacement. If you experienced adverse effects, report them to the FDA via MedWatch.

How often does Ion Beam Applications S.A. have FDA actions?

Ion Beam Applications S.A. has 11 FDA actions in our database, including 11 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "Z-0747-2022" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for device

Related Actions